AKT1 and cancer: Previous literature highlighted that PAQR3 could inhibit cell proliferation, migration, invasion, and EMT, by regulating the PI3K/AKT and Raf/MAPK/ERK signaling pathways in multiple cancers, including prostate, lung, and colorectal cancer [19–23].